https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:30017 Sat 24 Mar 2018 07:28:49 AEDT ]]> Onboarding of siponimod in secondary progressive multiple sclerosis patients in Australia: Novel, real-world evidence from the MSGo digital support programme https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54685 Fri 08 Mar 2024 11:52:11 AEDT ]]>